Lalwani Nikhilinsider trades
In SEC Form 4 filings, Lalwani Nikhil is listed as PRESIDENT & CEO of Ani Pharmaceuticals Inc (ANIP). In the last 90 days, Lalwani Nikhil sold $1.17M of Ani Pharmaceuticals Inc (ANIP) on the open market and bought none. All 3 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ANIPAni Pharmaceuticals Inc | PRESIDENT & CEO | 3 | Oct 16 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-26
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ANIPAni Pharmaceuticals Inc | Oct 15 | Oct 16 | S | 5,400 | $71.89 | Sale −$388,206 | 333,689 | Yes | Form 4 |
| ANIPAni Pharmaceuticals Inc | Sep 15 | Sep 16 | S | 5,400 | $71.00 | Sale −$383,400 | 339,089 | Yes | Form 4 |
| ANIPAni Pharmaceuticals Inc | Aug 25 | Aug 26 | S | 5,400 | $74.30 | Sale −$401,220 | 344,489 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.